Status of Chemistry Research in India

被引:0
|
作者
Singh, Vinod K. [1 ]
机构
[1] IIT Kanpur, Dept Chem, Kanpur 208016, Uttar Pradesh, India
来源
PROCEEDINGS OF THE INDIAN NATIONAL SCIENCE ACADEMY | 2020年 / 86卷 / 02期
关键词
D O I
暂无
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:877 / 877
页数:1
相关论文
共 50 条
  • [1] Status of Inorganic Chemistry Research in India
    Chandrasekhar, V
    Chakraborty, A.
    PROCEEDINGS OF THE INDIAN NATIONAL SCIENCE ACADEMY, 2020, 86 (02): : 983 - 999
  • [2] Status of Quantum Chemistry Research in India
    Pal, Sourav
    Ghosh, Swapan K.
    PROCEEDINGS OF THE INDIAN NATIONAL SCIENCE ACADEMY, 2020, 86 (02): : 975 - 982
  • [3] CURRENT STATUS OF THEORETICAL CHEMISTRY IN INDIA
    DEB, BM
    CURRENT SCIENCE, 1984, 53 (20): : 1061 - 1068
  • [4] Bioinorganic Chemistry Research in India
    Mugesh, G.
    PROCEEDINGS OF THE INDIAN NATIONAL SCIENCE ACADEMY, 2020, 86 (02): : 929 - 936
  • [5] The Prospect of Chemistry Research in India
    Deoghuria, Swapan
    Paul, Gayatri
    17TH INTERNATIONAL CONFERENCE ON SCIENTOMETRICS & INFORMETRICS (ISSI2019), VOL II, 2019, : 2640 - 2641
  • [6] Status of Cancer Research in India
    Sarma, Phulen
    Sharma, Parshant
    Singh, Rahul
    Mishra, Abhishek
    Kumar, Harish
    Bhattacharyya, Anusuya
    Harikrishnareddy, Dibbanti
    Singh, Ashutosh
    Medhi, Bikash
    PROCEEDINGS OF THE INDIAN NATIONAL SCIENCE ACADEMY, 2018, 84 (01): : 141 - 152
  • [7] Status of Neuropharmacology Research in India
    Gupta, Yogendra K.
    Katyal, Jatinder
    Gupta, Sangeetha
    PROCEEDINGS OF THE INDIAN NATIONAL SCIENCE ACADEMY, 2018, 84 (01): : 15 - 31
  • [8] Status of nanomedicine research in India
    Jain, N. K.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2006, 2 (04) : 297 - 297
  • [9] Status of toxicological research in India
    Flora, Swaran J. S.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2008, 21 (07) : 1317 - 1319
  • [10] Status of research on MMPs in India
    Saravanan, Chinnadurai
    Singh, Sushil Kumar
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (06) : 715 - 728